Treatment of CNS disorders using CNS target modulators

Details for Australian Patent Application No. 2005236073 (hide)

Owner Hypnion, Inc.

Inventors Leighton, Harry Jefferson; Edgar, Dale M.; Hangauer, David G.; Mignot, Emmanuel J. M.; White, James F.; Solomon, Michael; Shiosaki, Kazumi

Agent Cullen & Co

Pub. Number AU-A-2005236073

PCT Pub. Number WO2005/103041

Priority 10/831,553 23.04.04 US

Filing date 25 April 2005

Wipo publication date 3 November 2005

International Classifications

C07D 413/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/103041 Priority application(s): WO2005/103041

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005236074-Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants

2005236069-Inhibiting effects of sloughing in wellbores